Somatic mutations of the SA2 gene and loss of SA2 protein expression have been reported in multiple cancer cell lines, including urothelial bladder carcinomas, Ewing’s sarcomas, glioblastomas, and malignant melanomas (21). The gene discussed is STAG2; the disease is bladder transitional cell carcinoma.